APR 22, 2016 06:37 AM PDT

Common Aspirin Linked to Prolonged Cancer Survival

WRITTEN BY: Xuan Pham
Low-dose aspirin as an anti-cancer treatment?
Aspirin, formally known as acetylsalicylic acid (ASA), is one of the cheapest and most widely used over-the-counter drugs. This humble drug is used to treat a variety of health conditions like the common fevers, headaches, and inflammation. Doctors also prescribe this drug to reduce the risk of heart attacks for patients who have already had one.
 
In recent years, aspirin gained the spotlight again as more research linked it to anti-cancer potential. "There is a growing body of evidence that taking aspirin is of significant benefit in reducing some cancers," said Peter Elwood, professor at Cardiff University and first study author. Indeed, studies have previously linked aspirin to lowering the risks for colorectal and colon cancer by close to 20 percent. Likely, aspirin’s anti-inflammatory and anti-clotting properties play a part in its anti-cancer effects.
 
But the exact role of aspirin in cancer remains vague, as no one has really studied this link in depth.  "Whilst we know a low-dose of aspirin has been shown to reduce the incidence of cancer, its role in the treatment of cancer remains uncertain. As a result, we set out to conduct a systematic search of all the scientific literature," said Elwood.
 
To answer this question, Elwood and his team analyzed previous available data from 42 observational studies and 5 randomized trials of colorectal, breast and prostate cancers.
 
They found a 15-20 percent survival increase in patients who took low-dose aspirin, as compared to those who didn’t. Notably, Elwood highlighted the finding that cancer spread was also reduced with aspirin intake, suggesting the drug may reduce cancer metastasis.
 
 "Our review, based on the available evidence, suggests that low-dose aspirin taken by patients with bowel, breast or prostate cancer, in addition to other treatments, is associated with a reduction in deaths of about 15-20%, together with a reduction in the spread of the cancer,” said Elwood.
 
Though the team did not elaborate on mechanisms behind aspirin’s purported anti-cancer effects, they noted a genetic link between a mutation in the PI3KCA gene in about 20 percent of patients. “This appeared to explain much of the reduction in colon cancer mortality by aspirin,” said Elwood.
 
But before we hail aspirin as the miracle wonder drug, it’s important to remember this drug has serious side effects associated with long-term regular use. A daily dose of aspirin, even in its coated form, has the tendency to thin the stomach lining, increasing the risk of gastrointestinal bleeding and stomach inflammation. Stomach bleeding is no trivial matter, as it kills more Americans each year than asthma or cervical cancer.
 
Commenting on the health risks of aspirin, the authors concluded: "While there is a desperate need for more detailed research to verify our review and to obtain evidence on less common cancers, we'd urge patients diagnosed with cancer to speak to their doctor about our findings so they can make an informed decision as to whether or not they should take a low-dose aspirin as part of their cancer treatment.”
 

Additional sources: MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 17, 2018
Cancer
JUL 17, 2018
Experimental "Trojan Horse" Tumor Destruction Approach Using CRISPR
CRISPR can be used to dupe circulating tumor cells into killing their own main tumor after "re-homing" back with a death receptor for tumor destruction....
JUL 24, 2018
Cancer
JUL 24, 2018
Transfection, Transduction, and CRISPR...Oh My
CRISPR gene editing came about based on transfection and transduction type models of genetic transfer. There is potential for it to revolutionize gene editing but are there dangers lurking?...
AUG 21, 2018
Immunology
AUG 21, 2018
T cells Trapped by Brain Cancer
Brain tumors prevent T cells from escaping the bone marrow by altering levels of the S1P1 protein....
OCT 17, 2018
Cell & Molecular Biology
OCT 17, 2018
Saving Patients From Unnecessary Chemotherapy with a Blood Test
Often, cancer patients get chemotherapy after surgery to ensure that their cancer will not come back; for many it's not needed....
OCT 31, 2018
Cancer
OCT 31, 2018
Researchers identify a protein marker that induces dormancy in metastatic breast cancer
Researchers at the Mount Sinai hospital identified for the first time a protein marker that could indicate whether breast cancer will further metastasize or remains in a dormant state accordi...
DEC 09, 2018
Health & Medicine
DEC 09, 2018
Health Beliefs That Influence Skin Cancer
  In the U.S., there are over 3.5 million cases of skin cancer reported every year. Basal cell carcinoma and squamous cell carcinoma are the most comm...
Loading Comments...